Skip to main content
Premium Trial:

Request an Annual Quote

Huntington Willard

Geisinger Health System has named Huntington Willard as director of the newly launched Geisinger National Precision Health Initiative, to be based near Washington, DC. Among his duties, Willard will oversee formation of a new precision health innovation lab. Willard, who was founding director of the Duke Institute for Genome Sciences & Policy and is a former president of the American Society of Human Genetics, will start in January. 

The Scan

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.